Searched for
SURJIT PAL
Samyukta Kisan Morcha will not contest Punjab Assembly elections 2022The leaders said that the SKM, which is a platform of more than 400 different ideological organizations across the country, is formed only ...- USFDA reopens investigation of Aurobindo’s unit 4 facilityCo receives USFDA communique that inspection completed by the regulator in Nov 2019 is still open.
- LS polls: 'Baba Ji Burger Wale', 'Chacha Maggi Wala' in fray in PunjabAs many as 278 candidates are in the fray for the 13 Lok Sabha seats in Punjab where polling will be held on May 19, the last of the seven-...
- Sun Pharma up 3% on USFDA clean chit to Halol plantThe clearance brought to an end a two-year import ban the US drug regulator had imposed.
- USFDA clears Sun Pharma’s Halol plant, two years after it went under import banThe USFDA’s Establishment Inspection Report (EIR) comes days after the company received Voluntary Action Indicated (VAI) that indicated tha...
- Glenmark falls 5% on Venezuela concernsBrokerage firm Prabhudas Lilladher said in a research note that the country might even go for a currency devaluation.
- Venezuela’s vote for change has Indian pharma jitteryThe two companies whose stock might get impacted by changes are Glenmark and Dr Reddy’s, which have revenues worth $137 mn and $50 mn, resp...
- Pharma companies with big exposure to Russia fall with the roubleBSE Healthcare index fell by 2% at 14479 compared to its previous close of 14888 on Monday, the Sensex closed at 26781, down by 1.97%.
- US import alert on Ranbaxy; Mohali unit part of consent decreeThe health regulator added that as per the import alert the officials may detain at the US border drug products manufactured at Ranbaxy's M...
- Strides Arcolab scrip falls 12 per cent after getting a '483' letter from USFDAThe company has received a '483' missive because gloves were reused in the sterile injectables area, and the matter might be resolved soon.
- Wockhardt skids 20% on US warning over manufacturing practicesShares in Mumbai-based drug maker Wockhardt plunged 20% on Wednesday after details emerged of a warning by the US Food and Drug Administrat...
- Ranbaxy recalls generic Lipitor from the US marketRanbaxy today said it is recalling its generic version of cholesterol-lowering drug Lipitor from US market leading to temporary disruption ...
- Ex-Teva Frank Pieters to lead Cipla's European respiratory businessCipla, India's second-largest drug maker, has hired Teva's former vice-president Frank Pieters to spearhead its European respiratory busine...
- Wockhardt Pharma Q4 sales up, stock soars by 7%Mumbai based Wockhardt Pharma's stock price soared by 7 % at Rs 715 as the company beat the street estimates and posted a healthy Q4 margin...
- Pfizer scraps Insulin pact with BioconPfizer Inc has terminated a deal to sell Biocon's insulin products globally, dealing the Indian company a blow and calling into question si...
- Sun Pharma to export generic version of cancer medicine Lipidox to USShares of Sun Pharma rose 4% on Wednesday after the US drug regulator said it will import generic version of the cancer drug Lipidox.
- Dr Reddy's Laboratories splits marketing divisionDr Reddy's Laboratories (DRL) has split a key marketing division into two parts in a bid to resurrect its ailing domestic business.
- Watson Pharma launches Lipitor genericWatson’s launch raises questions on India’s third-largest drug company Ranbaxy Laboratories’ revenues from the drug.
- Murder outsourced in PunjabWhen murder is cheaper and less fraught with risk elsewhere, what's the logical thing to do?
- Wockhardt buys Morton Grove for $38 mnDomestic drug maker Wockhardt said on Wednesday it acquired US-based speciality drugs company Morton Grove Pharmaceuticals, which has annua...
Load More
